National Center for Health Statistics: 'Opioids Prescribed to Adults at Discharge From Emergency Departments: U.S., 2017-2020'
The data brief was written by
Here are excerpts:
* * *
Key findings
Data from the
* In 2019-2020, opioids were prescribed at discharge at 36.4 emergency department (ED) visits per 1,000 adults, compared with 50.5 ED visits in 2017-2018.
* The rate of ED visits with an opioid prescribed at discharge was lower in 2019-2020 than in 2017-2018 for both men and women.
* The percentage of ED visits with an opioid prescribed at discharge decreased from 12.2% in 2017-2018 to 8.1% in 2019-2020.
* The percentage of ED visits with an opioid prescribed at discharge decreased in 2019-2020 among non-Hispanic White and non-Hispanic Black people compared with 2017-2018.
* * *
Opioids may be an effective treatment for chronic and acute pain when properly used (1). However, receiving an opioid prescription in the emergency department (ED) has been identified as a potential risk factor for long-term use (2). Between 2010-2011 and 2016-2017, the percentage of opioids prescribed at ED discharge decreased from 21.5% to 14.6% (3,4). This report provides more recent changes in rates and percentages of opioids prescribed to adults (aged 18 and over) at discharge from the ED by patient and visit characteristics through 2020, using data from the
Did the rate of ED visits with an opioid prescribed at discharge change between 2017-2018 and 2019-2020?
* In 2019-2020, opioids were prescribed at discharge at 36.4 ED visits per 1,000 adults, which was lower than the 2017-2018 rate (50.5) (Figure 1)
* * *
Figure 1.: Rate of emergency department visits by adults with opioids prescribed at discharge, by sex:
* * *
* In 2019-2020, opioids were prescribed at discharge at 39.9 ED visits per 1,000 women and 32.6 ED visits per 1,000 men, both lower than the 56.6 and 43.9 ED visits for women and men, respectively, in 2017-2018.
* The rate of ED visits with opioids prescribed at discharge was higher for women (56.6 per 1,000 women) than men (43.9) in 2017-2018, but the observed difference in rates by sex for 2019-2020 was not significant.
Did the percentage of ED visits with opioids prescribed at discharge change by race and ethnicity between 2017-2018 and 2019-2020?
* Opioids were prescribed at discharge at 8.1% of ED visits made by adults in 2019-2020, which was lower than the percentage for 2017-2018 (12.2%) (Figure 2).
* The percentage of ED visits with an opioid prescribed at discharge decreased among non-Hispanic White people in 2019-2020 (8.3%) compared with 2017-2018 (12.9%). The percentage also decreased for visits by non-Hispanic Black people during the same period, to 7.2% from 11.1%. The observed decrease among Hispanic people (to 8.9% from 11.8%) was not significant.
* Percentages were similar across all race and ethnicity groups for 2019-2020 and 2017-2018.
* * *
Figure 2.: Percentage of emergency department visits by adults with opioids prescribed at discharge, by race and ethnicity:
* * *
Did the percentage of ED visits with opioids prescribed at discharge change by primary expected payment source between 2017-2018 and 2019-2020?
* The percentage of ED visits with opioids prescribed at discharge decreased in 2019-2020 compared with 2017-2018 across all primary expected sources of payment (Figure 3).
* During 2019-2020, the percentage of ED visits with opioids prescribed at discharge was higher for visits with private insurance (9.4%) compared with those with Medicare (7.1%).
Percentages were similar for Medicaid (8.4%) and no insurance (8.5%).
* During 2017-2018, the percentage of ED visits with opioids prescribed at discharge was higher for visits with private insurance (14.5%) and no insurance (14.0%) compared with visits with Medicare (10.5%) and Medicaid (10.8%).
* * *
Figure 3.: Percentage of emergency department visits by adults with opioids prescribed at discharge, by primary expected source of payment:
* * *
Summary
This report examines changes in rates and percentages of ED visits made by adults where opioids were prescribed at discharge.
In 2019-2020, the rate of ED visits with opioids prescribed at discharge decreased overall and among women and men compared with 2017-2018.
The percentage of ED visits with opioids prescribed at discharge decreased in 2019-2020 among all adults, among non-Hispanic White and non-Hispanic Black adults, and among visits according to all primary expected sources of payment compared with 2017-2018.
This report, based on the most recent estimates from NHAMCS on ED visits made by adults with opioids prescribed at discharge, shows a continued decreasing trend in opioid prescription patterns within the ED setting.
Definitions
ED visit rate: Calculated by dividing the number of 2017-2020 ED visits by adults with at least one opioid prescribed at discharge by the
Emergency department (ED) visits with opioids prescribed at discharge: Opioids were defined using the Cerner Multum third-level therapeutic category codes for narcotic analgesics (code 60) and narcotic analgesic combinations (code 191). Buprenorphine, buprenorphine-naloxone, and antitussive formulations containing opioids were not included. If any opioid mention in the visit record had the designation of "prescribed at discharge" or "both given in emergency department (ED) and prescribed at discharge," then that opioid was classified as an opioid prescribed at discharge. The unit of measurement is any opioid mention in the visit record.
Primary expected source of payment: During data collection, all sources of payment were collected. For patients with more than one source of payment, the following hierarchy is used, with Medicare counted first and self-pay and no charge counted last, to collapse payments into one mutually exclusive variable of primary expected source of payment.
Medicare: Partial or full payment by Medicare plan includes payments made directly to the hospital as well as payments reimbursed to the patient. Charges covered under a Medicare-sponsored prepaid plan are included.
Medicaid: Partial or full payment by a Medicaid plan includes payments made directly to the hospital or reimbursed to the patient. Charges covered under a Medicaid-sponsored prepaid plan (health maintenance organization) or "managed Medicaid" are included.
Private: Partial or full payment by a private insurer (as in BlueCross BlueShield), either directly to the hospital or reimbursed to the patient. Charges covered under a private insurance-sponsored prepaid plan are included.
Uninsured: Includes self-pay, no charge or charity. Self-pay are charges paid by the patient or patient's family that will not be reimbursed by a third party. Self-pay includes visits for which the patient is expected to be ultimately responsible for most of the bill, even if the patient never actually pays it. Copayments and deductibles are excluded. No charge or charity are visits for which no fee is charged, such as charity, special research, or teaching.
Data source and methods
Data for this report are from NHAMCS, an annual, nationally representative survey of nonfederal, general, and short-stay hospitals. NHAMCS uses a multistage probability design with samples of geographic primary sampling units (PSUs), hospitals within PSUs, and patient visits within EDs. Additional information on the methodology of NHAMCS has been described previously (5-8). This report presents results combining data for 2017-2018 and 2019-2020 to enable more detailed subgroup analyses. Estimates of the weighted number of visits are based on 2-year annual averages. Data analyses were performed using the statistical packages SAS version 9.4 (
* * *
About the authors
* * *
References
1. Dowell D, Ragan KR, Jones CM, Baldwin GT, Chou R.
2. Hoppe JA, Kim H,
3. Rui P, Schappert SM. Opioids prescribed at discharge or given during emergency department visits among adults in
4. Rui P, Santo L, Ashman JJ. Trends in opioids prescribed at discharge from emergency departments among adults:
5.
6.
7.
8.
9. Parker JD, Talih M, Malec DJ, Beresovsky V, Carroll M, Gonzalez JF Jr, et al.
* * *
The data brief is posted at: https://www.cdc.gov/nchs/data/databriefs/db461.pdf
Closing Medicaid coverage gap can't wait Karen Alexander and Patrick Woodie: Closing the coverage gap can't wait
Medicaid coverage starts slipping away for almost 1 million Floridians in April
Advisor News
Annuity News
Health/Employee Benefits News
Life Insurance News